SCHEMBL7090440

SCHEMBL7090440

CCN(CC)CCNC(=O)COc1cccc(-c2n[nH]c3c2Cc2ccccc2-3)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 8/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP3A4 P08684 1/20 0.44
CHEK1 O14757 3/20 0.43
CDK1 P06493 1/20 0.41
CDK2 P24941 1/20 0.41
HIF1A Q16665 1/20 0.40
LGALS1 P09382 1/20 0.40
KMT2A Q03164 2/20 0.39
PDGFRB P09619 1/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
RAD52 P43351 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LCK P06239 2/20 0.39
CSF1R P07333 2/20 0.39
KIT P10721 2/20 0.39
FLT1 P17948 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701562 0.93 KDR (0.44) KDRCHEK1CDK1CDK2HIF1A
SCHEMBL7136211 0.85 KDR (0.54) KDRCHEK1CDK1CDK2HIF1A
SCHEMBL7703314 0.84 KDR (0.53) KDRCHEK1CDK1CDK2HIF1A
SCHEMBL6993956 0.81 HSD17B10 (0.56) KDRCHEK1CDK2FLT3
SCHEMBL7000821 0.81 KDR (0.62) KDRCHEK1CDK1CDK2HIF1A
SCHEMBL7093643 0.80 KDR (0.53) KDRCHEK1CDK1CDK2HIF1A
SCHEMBL7088696 0.80 KDR (0.57) KDRCHEK1CDK1CDK2HIF1A
SCHEMBL7003316 0.79 CHEK1 (0.61) KDRCHEK1CDK1CDK2
SCHEMBL7093639 0.79 CHEK1 (0.52) KDRCHEK1CDK1CDK2SMN1; SMN2
Hydrochloric Acid SCHEMBL7095328 0.79 CHEK1 (0.60) KDRCYP3A4CHEK1CDK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed